Bioassay parallelism equivalence margin

ID: bioassay-parallelism-equivalence-margin

A bioassay parallelism equivalence margin is a prespecified range of curve-shape differences considered small enough for the intended relative biological potency comparison. It turns “sufficiently similar” into a testable criterion. A nonsignificant difference test does not establish that the possible difference lies inside this range.
For an original local model on log concentration , take reference and test responses and , with positive slopes. At a response level , their horizontal separation is
The change in log potency across a response band of width is therefore . This relates a slope-equivalence margin to the response range over which potency must remain approximately constant.
Suppose the allowed change in the equal-effect concentration ratio across that band is at most a factor 1.1 in either direction. The log-scale requirement is
With stipulated in the chosen response units, let . Then
approximately 0.9130–1.1054. This is an original conditional tolerance calculation, not a universal assay specification. Changing the response range or tolerated potency variation changes the margin.
An equivalence test asks whether an appropriately constructed uncertainty interval is contained within the acceptance range. An illustrative slope-ratio interval 0.95–1.05 lies inside the calculated range, while 0.88–1.12 does not. A slope criterion alone does not validate different upper or lower plateaus in a nonlinear curve. Response-range calibration of a bioassay equivalence margin should therefore accompany the chosen response model and experimental range.
A primary historical example is a 2017 collaborative rituximab-standard study. Its analysts assessed equivalence of upper asymptote, asymptote difference and slope parameters, and derived study-specific bounds from coded duplicate preparations. The report explicitly limits those bounds to that study rather than routine laboratory validity criteria.[ref]
This example illustrates a distinction between empirical reference-against-reference variation and a margin justified by the intended measurement. Document which argument sets each acceptance range. Include uncertainty from plate layout, biological replication and serial dilution; a narrow fitted interval under an incomplete noise model can overstate the evidence for bioassay parallelism. Predefine the analysis so that observed test-versus-reference disagreement does not silently determine its own acceptance criterion.

New to topics? Read the docs here!